Experience Growth & Success: Pharming Group to Announce Q2 and H1 2023 Financial Results on August 3

Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is pleased to announce that the preliminary (unaudited) financial results for its second quarter and first half of 2023, ending June 30, will be revealed on Thursday, August 3, 2023. Mark your calendars and stay tuned for what could be exciting news!

Join us on August 3, 2023 at 13:30 CEST/07:30 EDT for an informative and exciting presentation hosted by Pharming, covering key topics and insights for analysts and investors!

About Pharming Group N.V.

Headquartered in Leiden, Netherlands, Pharming Group N.V. is a global biopharmaceutical company transforming the lives of patients with rare and life-threatening diseases. With a focus on precision medicines, small molecules, biologics, and gene therapies, Pharming’s innovative portfolio of protein replacement therapies is in early to late-stage development.

The company is committed to making a difference in the lives of patients in more than 30 regions in North America, Europe, the Middle East, Africa, and Asia-Pacific, and its employees are at the forefront of this mission.

Leave a Comment